Try Alerts Free   |   Login
Health Care › Surgical and Medical Instruments And Apparatus

NARI Price Correlated With Financials For Inari Medical

Free historical financial statements for Inari Medical, Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 10 quarters since 2020. Compare with NARI stock chart to see long term trends.

NARI Stock Compared to Quarterly

NARI Income Statement

Revenue, Net:96204000
Revenue Per Share:1.7931
Cost of Goods & Services Sold:11064000
Gross Profit:85140000
Selling, General & Admin Expense:75833000
Research & Development Expense:19105000
Total Operating Expenses:94938000
Operating Income:-9798000
Income Taxes:840000
Net Income:-10153000
Earnings Per Share, Basic:-0.19
Shares Outstanding, Basic Avg:53652850

NARI Cash Flow

Operating Activities Net Income:
Change in Accounts Receiveable:5260000
Net Cash from Operations:-13066000
Net Cash from Operations Per Share:-0.2435
Net Cash from Financing Activities:3880000
Property, Plant & Equipment Purchases:2309000
Net Cash from Investing Activities:13402000
Net Change in Cash & Equivalents:3804000

NARI Balance Sheet

Cash and Cash Equivalents:83528000
Short-Term Investments:235705000
Accounts Receivable, Net:54059000
Inventories:29670000
Total Current Assets:410571000
Property, Plant & Equipment, Net:21191000
Total Assets:487819000
Accounts Payable:6035000
Total Short-Term Liabilities:42343000
Total Liabilities:72720000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock Inc.
5,415,796 sh
858,266 sh
19%
$393,404
$83,537
Wellington Management Group Llp
5,199,226 sh
402,875 sh
8%
$377,672
$51,569
Vanguard Group Inc
4,243,238 sh
242,983 sh
6%
$308,229
$36,252
Capital International Investors
2,924,062 sh
4,998 sh
0%
$212,404
$13,937
Macquarie Group Ltd
2,527,995 sh
-357,735 sh
-12%
$183,670
-$12,531
Franklin Resources Inc
2,268,976 sh
451,598 sh
25%
$164,819
$41,255
Alliancebernstein L.P.
2,180,170 sh
-440,468 sh
-17%
$158,368
-$19,809
State Street Corp
1,552,608 sh
249,751 sh
19%
$112,781
$24,200
Invesco Ltd.
1,541,832 sh
-195,246 sh
-11%
$111,998
-$6,105
Allspring Global Investments Holdings, LLC
1,235,812 sh
-77,701 sh
-6%
$89,768
$465
Brown Advisory Inc
1,101,520 sh
-17,755 sh
-2%
$80,014
$3,915
Geode Capital Management, LLC
869,524 sh
137,733 sh
19%
$63,162
$13,408
Eaton Vance Management
687,489 sh
-9 sh
0%
$49,939
$3,196
Northern Trust Corp
678,028 sh
291,598 sh
75%
$49,252
$14,226
Price T Rowe Associates Inc /Md/
663,048 sh
-1,303,254 sh
-66%
$48,164
-$85,525
Lord, Abbett & Co. LLC
565,857 sh
107,291 sh
23%
$41,104
$9,926
Credit Suisse Ag/
550,370 sh
2,645 sh
0%
$39,979
$2,740
Millennium Management LLC
494,340 sh
188,410 sh
62%
$35,909
$15,109
Bank Of New York Mellon Corp
486,423 sh
103,966 sh
27%
$35,333
$9,330
Goldman Sachs Group Inc
442,506 sh
133,928 sh
43%
$32,143
$11,163
COMPANY PROFILE
1. Organization Description of Busine ss Inari Medical, Inc. (the “Company”) was incorporated in Delaware in July 2011 and is headquartered in Irvine, California. The Company develops, manufactures, markets and sells devices for the interventional treatment of venous diseases.

Data imported from Inari Medical, Inc. SEC filings. Check original filings before making any investment decision.